Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017869
Filing Date
2022-11-14
Accepted
2022-11-14 17:23:32
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20220930x10q.htm   iXBRL 10-Q 2047470
2 EX-10.1 rsls-20220930xex10d1.htm EX-10.1 147077
3 EX-31.1 rsls-20220930xex31d1.htm EX-31.1 11734
4 EX-31.2 rsls-20220930xex31d2.htm EX-31.2 11982
5 EX-32.1 rsls-20220930xex32d1.htm EX-32.1 9407
6 EX-32.2 rsls-20220930xex32d2.htm EX-32.2 9220
  Complete submission text file 0001558370-22-017869.txt   8194793

Data Files

Seq Description Document Type Size
7 EX-101.SCH rsls-20220930.xsd EX-101.SCH 43869
8 EX-101.CAL rsls-20220930_cal.xml EX-101.CAL 61851
9 EX-101.DEF rsls-20220930_def.xml EX-101.DEF 241941
10 EX-101.LAB rsls-20220930_lab.xml EX-101.LAB 410341
11 EX-101.PRE rsls-20220930_pre.xml EX-101.PRE 365438
62 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20220930x10q_htm.xml XML 1457270
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37897 | Film No.: 221387909
SIC: 3841 Surgical & Medical Instruments & Apparatus